期刊文献+

曲古菌素A在胃腺癌细胞系SGC-7901中的作用 被引量:2

Impact of trichostatin A on gastric carcinoma cell line SGC-7901
原文传递
导出
摘要 目的研究曲古菌素A(TSA)在胃腺癌细胞系SGC-7901中的作用。方法四甲基偶氮唑蓝法测定TSA对SGC-7901的细胞毒性,荧光显微镜观察细胞核DNA的变化,流式细胞仪检测细胞周期和凋亡率,Western印迹检测组蛋白H3的乙酰化状态。结果SGC-7901细胞生长曲线表明,TSA浓度增高,细胞生长率下降。细胞凋亡率在75ng/mlTSA作用72h时与对照组比较,差异有统计学意义(P〈0.05)。凋亡细胞DNA变化主要表现为核染色质固缩及断裂,荧光染色增强。流式细胞仪分析出现明显的亚G1期峰,G1期细胞减少,细胞凋亡率达29.54%。TSA作用后,乙酰化的组蛋白如明显增多。结论TSA可以诱导SGC-7901细胞发生凋亡,组蛋白H3的乙酰化状态可能与细胞凋亡有关。 Objective To investigate the effect of trichostatin A (TSA) on SGC-7901 cells. Methods Cytotoxicity and cell viability of gastric cancer cell line SGC-7901 were assayed by MTT method. Morphologic assessment of apoptosis was performed with fluorescence microscope. Cell cycle and apoptosis rate were analyzed by flow cytometry. Histone H3 acetylation was detected by Western blot. Results TSA showed apparently cytotoxicity in SGC-7901 cells. The growth curve showed the growth ratio decreased with the increase of TSA concentration. Apoptosis rate were significantly different between TSA treated group(75 ng/ml for 72 h)and control group (P 〈 0.05). Morphologic changes of apoptosis including nuclear chromatin condensation and fluorescence strength were observed with fluorescence microscope.TSA treatment (75 ng/ml for 72 h) sensitively induced apoptosis in the cell,which was demonstrated by the migration of many cells to the sub-Gl phase,the reduction of G1- phase cells and the increament of apoptosis rate (29.54%) in flow cytometric analysis. The expression of acetylated histone H3 was increased in TSA group (75 ng/ml) for 48 h compared with control group by Western blot. Conchisions TSA can induce SGC-7901 cell apoptosis. The expression of acetylated histone H3 may contribute to the apoptosis.
出处 《中华胃肠外科杂志》 CAS 2007年第4期376-379,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肿瘤 曲古菌素A 细胞凋亡 乙酰化组蛋白H3 细胞系SGC-7901 Stomach neoplasms Trichostatin A Apoptosis Acetylated histone H3 Cell line SGC-7901
  • 相关文献

参考文献9

  • 1Vigushin DM, Ali S, Pace PE, et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res, 2001,7:971-976.
  • 2Vogt PK. Jun, the oncoprotein. Oncogene, 2001,20:2365- 2377.
  • 3Dhordain P, Lin R J, Quief S, et al. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/ histone deacetylase containing compel to mediate transcriptional repession. Nucleic Acids Res, 1998,26 : 4645-4651.
  • 4Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors : inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst, 2000,92: 1210-1216.
  • 5Duan H, Heckman CA, Boxer LM. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14; 18) Iymphomas. Mol Cell Biol, 2005,25: 1608-1619.
  • 6陈维凯,陈燕,谷俊侠,崔国惠.曲古菌素A对HL-60细胞组蛋白乙酰化水平和凋亡的作用[J].中国实验血液学杂志,2004,12(3):324-328. 被引量:11
  • 7洪振亚,易莉莎,苗新宇,卢运萍,周剑锋,刘文励.应用基因芯片分析曲古菌素A促人白血病细胞株Molt-4凋亡的机制[J].癌症,2006,25(8):946-953. 被引量:6
  • 8Kwon SH, Ahn SH, Kim YK, et al. Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells. J Biol Chem, 2002,277 : 2073-2080.
  • 9De Schepper S, Bruwiere H, Verhulst T, et al. Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of surviving. J Pharmacol Exp Ther, 2003,304 : 881-888.

二级参考文献33

  • 1Medina V,Edmonds B,Young GP,et al.Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome C-dependent pathway.Ca
  • 2Ailenberg M,Silverman M.Differential effects of trichostatin A on gelatinase A expression in 3T3 fibroblasts and HT-1080 fibrossrcoma cells: implications for use of TSA in cancer therapy.Biochem Biophys Res Commun,2003; 302:181 - 185
  • 3Suzuki T,Yokozaki H,Kuniyasu H,et al.Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines.Int J Cancer,2000; 88: 992 - 997
  • 4Redner RL,Wang JX,Liu JM.Chromatin remodeling and leukemia: new therapeutic paradigms.Blood,1999; 94:417-428
  • 5Kosugi H,Towatari M,Hatano S,et al.Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myaloid leukemia:a new approach to anti-leukemia therapy.Leukemia,1999; 13:1316- 1324
  • 6Wang J,Saunthararajah Y,Render RL,et al.Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells.Cancer Res,1999; 59: 2766 -2769
  • 7De-Schepper S,Bruwiere H,Verhulst T,et al.Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasomemediated degradation of survivin.J Pharmacol Exp Ther,2003;304:881 - 888
  • 8Kwon SH,Ahn SH,Kim YK,et al.Apicidin,a histone deacetylase inhibitor,induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia Cells.J Biol Chem,2002; 277:2073 - 2080
  • 9Vigushin DM,Ali S,Pace PE,et al.Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.Clin Cancer Res,2001; 7:971 - 976
  • 10Nervi C,Borello U,Fazi F,et al.Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity.Cancer Res,2001; 61:1247 - 1249

共引文献11

同被引文献3

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部